Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marina M Roytman

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Clinical Pharmacology and Therapeutics|June 20, 2018
Botanicals and HepatotoxicityMarina M Roytman, Peter Poerzgen, Victor Navarro
Journal of Hospital Medicine|February 8, 2008
Comparison of practice patterns of hospitalists and community physicians in the care of patients with congestive heart failureMarina M Roytman, Sean M Thomas, Caroline S Jiang
Hawai'I Journal of Medicine & Public Health : a Journal of Asia Pacific Medicine & Public Health|September 21, 2013
Trial and error: investigational drug induced liver injury, a case series reportAshley Marumoto, Marina M Roytman, Naoky C S Tsai
Hawai'I Journal of Medicine & Public Health : a Journal of Asia Pacific Medicine & Public Health|August 18, 2015
Autoimmune Hepatitis in Hawai'iTanner I Kim, Jaclyn E Kagihara, Naoky C S Tsai, et al.
The American Journal of Gastroenterology|August 6, 2014
Outbreak of severe hepatitis linked to weight-loss supplement OxyELITE ProMarina M Roytman, Peter Pörzgen, Christine L Lee, et al.
Hawai'I Journal of Medicine & Public Health : a Journal of Asia Pacific Medicine & Public Health|January 22, 2016
Real-world Experience with Sofosbuvir-based Regimens for Chronic Hepatitis C, Including Patients with Factors Previously Associated with Inferior Treatment ResponseChristina J Wu, Marina M Roytman, Leena K Hong, et al.
Hawai'I Journal of Medicine & Public Health : a Journal of Asia Pacific Medicine & Public Health|September 21, 2013
New triple therapy for chronic hepatitis C: real life clinical experience in a community settingMatthew J Akiyama, Joy I Piotrowski, Marina M Roytman, et al.
Digestive Diseases and Sciences|March 31, 2015
Poor Sustained Virological Response in a Multicenter Real-Life Cohort of Chronic Hepatitis C Patients Treated with Pegylated Interferon and Ribavirin plus Telaprevir or BoceprevirKevin P Vo, Philip Vutien, Matthew J Akiyama, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Clinical Pharmacology and Therapeutics|June 20, 2018
Botanicals and HepatotoxicityMarina M Roytman, Peter Poerzgen, Victor Navarro
Journal of Hospital Medicine|February 8, 2008
Comparison of practice patterns of hospitalists and community physicians in the care of patients with congestive heart failureMarina M Roytman, Sean M Thomas, Caroline S Jiang
Hawai'I Journal of Medicine & Public Health : a Journal of Asia Pacific Medicine & Public Health|September 21, 2013
Trial and error: investigational drug induced liver injury, a case series reportAshley Marumoto, Marina M Roytman, Naoky C S Tsai
Hawai'I Journal of Medicine & Public Health : a Journal of Asia Pacific Medicine & Public Health|August 18, 2015
Autoimmune Hepatitis in Hawai'iTanner I Kim, Jaclyn E Kagihara, Naoky C S Tsai, et al.
The American Journal of Gastroenterology|August 6, 2014
Outbreak of severe hepatitis linked to weight-loss supplement OxyELITE ProMarina M Roytman, Peter Pörzgen, Christine L Lee, et al.
Hawai'I Journal of Medicine & Public Health : a Journal of Asia Pacific Medicine & Public Health|January 22, 2016
Real-world Experience with Sofosbuvir-based Regimens for Chronic Hepatitis C, Including Patients with Factors Previously Associated with Inferior Treatment ResponseChristina J Wu, Marina M Roytman, Leena K Hong, et al.
Hawai'I Journal of Medicine & Public Health : a Journal of Asia Pacific Medicine & Public Health|September 21, 2013
New triple therapy for chronic hepatitis C: real life clinical experience in a community settingMatthew J Akiyama, Joy I Piotrowski, Marina M Roytman, et al.
Digestive Diseases and Sciences|March 31, 2015
Poor Sustained Virological Response in a Multicenter Real-Life Cohort of Chronic Hepatitis C Patients Treated with Pegylated Interferon and Ribavirin plus Telaprevir or BoceprevirKevin P Vo, Philip Vutien, Matthew J Akiyama, et al.
Pageof 1